In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication

INTRODUCTION: Letermovir (LMV) is used for prophylaxis of cytomegalovirus (CMV) reactivation and end-organ disease in adult CMV-seropositive allogeneic hematopoietic stem cell transplant recipients (allo-HSCT). In turn, sirolimus (SLM) which displays in vitro anti-CMV activity, is frequently employe...

Descripción completa

Detalles Bibliográficos
Autores principales: Giménez, Estela, Guerreiro, Manuel, Gozalbo-Rovira, Roberto, Aguilar, Cristobal, Albert, Eliseo, Piñana, José Luis, Solano, Carlos, Navarro, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586729/
https://www.ncbi.nlm.nih.gov/pubmed/37365797
http://dx.doi.org/10.37201/req/016.2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586729/
https://www.ncbi.nlm.nih.gov/pubmed/37365797
http://dx.doi.org/10.37201/req/016.2023

Ejemplares similares